Treating opioid dependency and coexistent chronic nonmalignant pain

American Family Physician

Volumn 78, Issue 10, 2008, Pages 1132-1133

  Blondell, Richard D ^a   Ashrafioun, Lisham ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; METHADONE; NALOXONE; OPIATE; NARCOTIC ANALGESIC AGENT;

ACCIDENT PRONENESS; ANALGESIA; CHRONIC PAIN; COGNITION; COGNITIVE THERAPY; CONSTIPATION; DRUG EFFICACY; DRUG SCREENING; EDITORIAL; HUMAN; LOW BACK PAIN; OPIATE ADDICTION; PATIENT MONITORING; PRIMARY MEDICAL CARE; QUESTIONNAIRE; CHRONIC DISEASE; NOTE; PAIN;

ANALGESICS, OPIOID; BUPRENORPHINE; CHRONIC DISEASE; HUMANS; METHADONE; OPIOID-RELATED DISORDERS; PAIN;

EID: 58149201621     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Jackman R, Purvis JM, Mallett BS. Chronic nonmalignant pain in primary care. Am Fam Physician. 2008;78(10):1155-1162.
2. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116-127. (Pubitemid 351640015)
3. Streltzer J, Johansen L. Prescription drug dependence and evolving beliefs about chronic pain management. Am J Psychiatry. 2006;163(4):594-598. (Pubitemid 44464567)
4. Schieffer BM, Pham Q, Labus J, et al. Pain medication beliefs and medication misuse in chronic pain. J Pain. 2005;6(9):620-629. (Pubitemid 43300600)
5. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain. 1985;23(4):345-356. (Pubitemid 16212847)
6. VA/DoD clinical practice guideline for the management of opioid therapy for chronic pain. Washington, DC: Veterans Health Administration, Department of Defense; 2003.
7. http://www.guideline.gov/summary/summary.aspx?doc-id=4812&nbr= 003474&string=chronic+AND+pain. Accessed May 28, 2008.
8. Kennedy JA, Crowley TJ. Chronic pain and substance abuse: a pilot study of opioid maintenance. J Subst Abuse Treat. 1990;7(4):233-238.
9. Heel RC, Brogden RN, Speight TM, Avery GS. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs. 1979;17(2):81-110. (Pubitemid 11144150)
10. Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage. 2005;29(3):297-326.
11. Rhodin A, Grönbladh L, Nilsson LH, Gordh T. Methadone treatment of chronic non-malignant pain and opioid dependence-a long-term follow-up. Eur J Pain. 2006;10(3):271-278. (Pubitemid 43255214)
12. Malinoff HL, Barkin RL, Wilson G. Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. Am J Ther. 2005;12(5): 379-3 84. (Pubitemid 41445134)